Search Results - "первичное чрескожное коронарное вмешательство"

1

Academic Journal

The role of therapeutic hypothermia in reducing of the reperfusion injury in patients with STEMI: narrative review ; Роль терапевтической гипотермии в снижении реперфузионного повреждения у пациентов со STEMI: нарративный обзор

Authors: Yu. I. Bogdanov, A. E. Baev, V. V. Ryabov, S. E. Pekarsky, E. S. Gergert, R. M. Gromovoy, M. G. Tarasov, S. M. Sultanov, I. V. Suslov, Ю. И. Богданов, А. Е. Баев, В. В. Рябов, С. Е. Пекарский, Е. С. Гергерт, Р. М. Громовой, М. Г. Тарасов, С. М. Султанов, И. В. Суслов

Source: Siberian Journal of Clinical and Experimental Medicine; Том 39, № 3 (2024); 19-25 ; Сибирский журнал клинической и экспериментальной медицины; Том 39, № 3 (2024); 19-25 ; 2713-265X ; 2713-2927

Subject Terms: тромбоаспирация, myocardial infarction, hypothermia, primary percutaneous coronary intervention, thrombus aspiration, инфаркт миокарда, гипотермия, первичное чрескожное коронарное вмешательство

File Description: application/pdf

Relation: https://www.sibjcem.ru/jour/article/view/1980/987; Delbridge M.S., Shrestha B.M., Raftery A.T., El Nahas A.M., Haylor J.L. The effect of body temperature in a rat model of renal ischemia-reperfusion injury. Transplant. Proc. 2007;39(10):2983–2985. DOI:10.1016/j.transproceed.2007.04.028.; Zager R.A., Gmur D.J., Bredl C.R., Eng M.J. Degree and time sequence of hypothermic protection against experimental ischemic acute renal failure. Circ. Res. 1989;65(5):1263–1269. DOI:10.1161/01.res.65.5.1263.; Kuboyama K., Safar P., Radovsky A., Tisherman S.A., Stezoski S.W., Alexander H. Delay in cooling negates the beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, randomized study. Crit. Care Med. 1993;21(9):1348–1358. DOI:10.1097/00003246-199309000-00019.; Tissier R., Chenoune M., Ghaleh B., Cohen M.V., Downey J.M., Berdeaux A. The small chill: mild hypothermia for cardioprotection? Cardiovasc. Res. 2010;88(3):406–414. DOI:10.1093/cvr/cvq227.; Engelman R., Baker R.A., Likosky D.S., Grigore A., Dickinson T.A., Shore-Lesserson L. et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: clinical practice guidelines for cardiopulmonary bypass –temperature management during cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 2015;29(4):1104–1113. DOI:10.1053/j.jvca.2015.07.011.; Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N. Engl. J. Med. 2002;346(8):549–556. DOI:10.1056/NEJMoa012689.; Post H., Schmitto J.D., Steendijk P., Christoph J., Holland R., Wachter R. et al. Cardiac function during mild hypothermia in pigs: increased inotropy at the expense of diastolic dysfunction. Acta Physiol. (Oxf.). 2010;199(1):43–52. DOI:10.1111/j.1748-1716.2010.02083.x.; Ujhelyi M.R., Sims J.J., Dubin S.A., Vender J., Miller A.W. Defibrillation energy requirements and electrical heterogeneity during total body hypothermia. Crit. Care Med. 2001;29(5):1006–1011. DOI:10.1097/00003246-200105000-00025.; Rolfast C.L., Lust E.J., de Cock C.C. Electrocardiographic changes in therapeutic hypothermia. Crit. Care. 2012;16:R100. DOI:10.1186/cc11369.; Rankin A.C., Rae A.P. Cardiac arrhythmias during rewarming of patients with accidental hypothermia. Br. Med. J. (Clin. Res. Ed.). 1984;289(6449):874–877. DOI:10.1136/bmj.289.6449.874.; Noc M., Erlinge D., Neskovic A.N., Kafedzic S., Merkely B., Zima E. et al. COOL AMI EU pilot trial: a multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction. EuroIntervention. 2017;13(5):e531–e539. DOI:10.4244/EIJ-D-17-00279.; Manninger M., Alogna A., Zweiker D., Zirngast B., Reiter S., Herbst V. et al. Mild hypothermia (33°C) increases the inducibility of atrial fibrillation: An in vivo large animal model study. Pacing Clin. Electrophysiol. 2018;41(7):720–726. DOI:10.1111/pace.13351.; Thomsen J.H., Hassager C., Erlinge D., Nielsen N., Horn J., Hovdenes J. et al. Atrial fibrillation following out-of-hospital cardiac arrest and targeted temperature management – Are we giving it the attention it deserves? Crit. Care Med. 2016;44(12):2215–2222. DOI:10.1097/CCM.0000000000001958.; Kudlicka J., Mlcek M., Belohlavek J., Hala P., Lacko S., Janak D. et al. Inducibility of ventricular fibrillation during mild therapeutic hypothermia: electrophysiological study in a swine model. J. Transl. Med. 2015;13:72. DOI:10.1186/s12967-015-0429-9.; Polderman K.H. Mechanisms of action, physiological effects, and complications of hypothermia. Crit. Care Med. 2009;37(7 Suppl.):S186– S202. DOI:10.1097/CCM.0b013e3181aa5241.; Suga H., Goto Y., Igarashi Y., Yasumura Y., Nozawa T., Futaki S. et al. Cardiac cooling increases Emax without affecting relation between O2 consumption and systolic pressure-volume area in dog left ventricle. Circ. Res. 1988;63:61–71. DOI:10.1161/01.res.63.1.61.; Bergmann S.R., Angelakos E.T., Torres J.C. Salutary effects of moderate hypothermia on the circulatory and myocardial consequences of acute coronary occlusion in dogs. Cryobiology. 1985;22(6):555–568. DOI:10.1016/0011-2240(85)90032-x.; Hodges G.J., Ferguson S.A.H., Cheung S.S. Cardiac autonomic function during hypothermia and its measurement repeatability. Appl. Physiol. Nutr. Metab. 2019;44(1):31–36. DOI:10.1139/apnm-2018-0248.; Rose J.C., McDermott T.F., Lilienfield L.S., Porfido F.A., Kelley R.T. Cardiovascular function in hypothermic anesthetized man. Circulation. 1957;15(4):512–517. DOI:10.1161/01.CIR.15.4.512.; Schwarzl M., Huber S., Maechler H., Steendijk P., Seiler S., Truschnig-Wilders M. et al. Left ventricular diastolic dysfunction during acute myocardial infarction: effect of mild hypothermia. Resuscitation. 2012;83(12):1503–1510. DOI:10.1016/j.resuscitation.2012.05.011.; Simkhovich B.Z., Hale S.L., Kloner R.A. Metabolic mechanism by which mild regional hypothermia preserves ischemic tissue. J. Cardiovasc. Pharmacol. Ther. 2004;9(2):83–90. DOI:10.1177/107424840400900203.; Fairley H.B. Metabolism in hypothermia. Br. Med. Bull. 1961;17:52–55. DOI:10.1093/oxfordjournals.bmb.a069865.; Ziganshin B.A., Elefteriades J.A. Deep hypothermic circulatory arrest. Ann. Cardiothorac. Surg. 2013;2(3):303–315. DOI:10.3978/j.issn.2225-319X.2013.01.05.; Jones R.N., Reimer K.A., Hill M.L., Jennings R.B. Effect of hypothermia on changes in high-energy phosphate production and utilization in total ischemia. J. Mol. Cell. Cardiol. 1982;14(3):123–130. DOI:10.1016/0022-2828(82)90140-7.; Hausenloy D.J., Yellon D.M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 2013;123(1):92–100. DOI:10.1172/JCI62874.; Inoue K., Ando S., Gyuan F., Takaba T. A study of the myocardial protective effect of rapid cooling based on intracellular Ca, intracellular pH, and HSP70. Ann. Thorac. Cardiovasc. Surg. 2003;9(5):301–306. URL: https://pubmed.ncbi.nlm.nih.gov/14672526/ (28.06.2023).; Xu L., Yenari M.A., Steinberg G.K., Giffard R.G. Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J. Cereb. Blood Flow Metab. 2002;22(1):21–28. DOI:10.1097/00004647-200201000-00003.; Krech J., Tong G., Wowro S., Walker C., Rosenthal L.M., Berger F. et al. Moderate therapeutic hypothermia induces multimodal protective effects in oxygen-glucose deprivation/reperfusion injured cardiomyocytes. Mitochondrion. 2017;35:1–10. DOI:10.1016/j.mito.2017.04.001.; Ning X.H., Chen S.H., Xu C.S., Li L., Yao L.Y., Qian K. et al. Hypothermic protection of the ischemic heart via alterations in apoptotic pathways as assessed by gene array analysis. J. Appl. Physiol. 1985. 2002;92:2200– 2207. DOI:10.1152/japplphysiol.01035.2001.; Dash R., Mitsutake Y., Pyun W.B., Dawoud F., Lyons J., Tachibana A. et al. Dose-dependent cardioprotection of moderate (32 °C) versus mild (35 °C) therapeutic hypothermia in porcine acute myocardial infarction. JACC Cardiovasc. Interv. 2018;11(2):195–205. DOI:10.1016/j.jcin.2017.08.056.; Hale S.L., Dave R.H., Kloner R.A. Regional hypothermia reduces myocardial necrosis even when instituted after the onset of ischemia. Basic. Res. Cardiol. 1997;92(5):351–357. DOI:10.1007/BF00788947.; Baraka A. Influence of surface cooling and rewarming on whole-body oxygen supply-demand balance. Br. J. Anaesth. 1994;73(3):418–420. DOI:10.1093/bja/73.3.418.; Bro-Jeppesen J., Annborn M., Hassager C., Wise M.P., Pelosi P., Nielsen N. et al. Hemodynamics and vasopressor support during targeted temperature management at 33 degrees C Versus 36 degrees C after out-of-hospital cardiac arrest: a post hoc study of the target temperature management trial. Crit. Care Med. 2015;43(2):318–327. DOI:10.1097/CCM.0000000000000691.; Furnau G., Beck J., Desch S., Eitel I., Jung C., Erbs S. et al. Mild hypothermia in cardiogenic shock complicating myocardial infarction – the randomized SHOCK-COOL pilot trial. Wien. Klin. Wochenschr. 2017;129:S94. DOI:10.1016/S0735-1097(17)34572-2.; Ly H.Q., Denault A., Dupuis J., Vadeboncoeur A., Harel F., Arsenault A. et al. A pilot study: the noninvasive surface cooling thermoregulatory system for mild hypothermia induction in acute myocardial infarction (The NICAMI study). Am. Heart J. 2005;150:933. DOI:10.1016/j.ahj.2005.02.049.; Otterspoor L.C., Van’t Veer M., van Nunen L.X., Brueren G.R.G., Tonino P.A.L., Wijnbergen I.F. et al. Safety and feasibility of selective intracoronary hypothermia in acute myocardial infarction. Eurointervention. 2017;13(12):E1475–E1482. DOI:10.4244/EIJ-D-17-00240.; Gotberg M., Olivecrona G.K., Koul S., Carlsson M., Engblom H., Ugander M., et al. A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction. Circ. Cardiovasc. Inte. 2010;3(5):400–407. DOI:10.1161/CIRCINTERVENTIONS.110.957902.; Dae M., O’Neill W., Grines C., Dixon S., Erlinge D., Noc M. et al. Effects of endovascular cooling on infarct size in ST-segment elevation myocardial infarction: A patient-level pooled analysis from randomized trials. J. Interv. Cardiol. 2018;31(3):269–276. DOI:10.1111/joic.12485.; Kapur N.K., Alkhouli M.A., DeMartini T.J., Faraz H., George Z.H., Goodwin M.J. et al. Unloading the left ventricle before reperfusion in patients with anterior ST-segment-elevation myocardial infarction. Circulation. 2019;139(3):337–346. DOI:10.1161/CIRCULATIONAHA.118.038269.; https://www.sibjcem.ru/jour/article/view/1980

Availability: https://www.sibjcem.ru/jour/article/view/1980
https://doi.org/10.29001/2073-8552-2023-581

View record from BASE

2

Academic Journal

Преодоление географических барьеров в лечении острого инфаркта миокарда в России

Source: Демографическое обозрение, Vol 6, Iss 1, Pp 104-123 (2019)

Subject Terms: инфаркт миокарда (ИМ), Demography. Population. Vital events, 03 medical and health sciences, Россия, 0302 clinical medicine, первичное чрескожное коронарное вмешательство (ЧКВ), HB848-3697, транспортная доступность, время доезда

Access URL: https://demreview.hse.ru/article/download/9783/10690
https://doaj.org/article/0e25db3b802b4aea943c14b823da7136
https://demreview.hse.ru/article/download/9783/10690
https://demreview.hse.ru/article/view/9783

View record at OpenAIRE Full Text Finder

3

Academic Journal

Efficacy of manual thrombaspiration in patients with myocardial infarction: a review of literature data

Authors: S.A. Boldueva, D.S. Maznev, I.A. Leonova

Source: Emergency Cardiology. :14-19

Subject Terms: 2. Zero hunger, мануальная тромбаспирация, myocardial infarction, первичное чрескожное коронарное вмешательство, manual thrombaspiration, primary percutaneous coronary intervention, инфаркт миокарда, 3. Good health

4

Academic Journal

Clinical and epidemiological features of acute coronary syndrome in the city of Kemerovo

Authors: V. I. Ganyukov, D.Yu. Naumov, M.A. Sinkov

Source: Emergency Cardiology. :3-11

Subject Terms: 2. Zero hunger, STEMI, первичное чрескожное коронарное вмешательство, 11. Sustainability, Kemerovo and Kemerovo region, ОКСбпST, non- STEMI, острый коронарный синдром, ОКСпST, primary percutaneous coronary intervention, Кемерово и Кемеровская область, 3. Good health, acute coronary syndrome

5

Academic Journal

LIMITATIONS ON PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION IN THE CLINICAL PRACTICE

Authors: V. V. Kashtalap, A. M. Kochergina, S. A. Makarov, V. Yu. Kheraskov, O. L. Barbarash

Source: Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 40-46 (2016)

Subject Terms: пожилой возраст, 03 medical and health sciences, myocardial infarction, 0302 clinical medicine, первичное чрескожное коронарное вмешательство, RC666-701, Diseases of the circulatory (Cardiovascular) system, primary percutaneous coronary intervention, инфаркт миокарда, advanced age, 3. Good health

Access URL: https://www.heartj.asia/jour/article/download/5663/5665
https://doaj.org/article/78b33056858c4594b0fbc36415c1a1a2

View record at OpenAIRE

6

Academic Journal

Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction ; Сравнение болюсного интракоронарного и болюсного внутривенного путей введения эптифибатида во время первичного чрескожного коронарного вмешательства у пациентов с передним инфарктом миокарда с подъемом сегмента ST

Authors: Mohamed Nab Hassan, Shaimaa Mostafa, Khaled Elrabat, Hamza Kabil, Neama Elmelegy, Мохамед Наб Хассан, Шайма Мостафа, Халид Эльрабат, Хамза Кабил, Нэма Элмелеги

Source: Rational Pharmacotherapy in Cardiology; Vol 15, No 1 (2019); 17-28 ; Рациональная Фармакотерапия в Кардиологии; Vol 15, No 1 (2019); 17-28 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2019-15-1

Subject Terms: intracoronary eptifibatide, intravenous eptifibatide, primary percutaneous coronary intervention, интракоронарное введение эптифибатида, внутривенное введение эптифибатида, первичное чрескожное коронарное вмешательство

File Description: application/pdf

Relation: https://www.rpcardio.com/jour/article/view/1853/1764; https://www.rpcardio.com/jour/article/view/1853/1765; Brener S.J., Cristea E., Mehran R. et al. Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: the harmonizing outcomes with revascularization and stents in AMI (HORIZONS-AMI) trial. Am Heart J. 2011;162(6):1044-51. doi:10.1016/j.ahj.2011.08.022.; Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy (ESPRIT) Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized placebo controlled trial: Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy. Lancet. 2000;356:2037-44. doi:10.1016/S0140-6736(00)03400-0.; Stone G.W., Maehara A., Witzenbichler B. et al. INFUSE-AMI Investigators. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA. 2012;307(17):1817-26. doi:10.1001/jama.2012.421.; Bittl J.A. Abciximab During Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2013;61(13):1455-7. doi:10.1016 /j.jacc.2013.01.042.; Zeymer U., Margenet A., Haude M. et al. Randomized Comparison of Eptifibatide Versus Abciximab in Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2010;56(6):463-9. doi:10.1016/j.jacc.2009.08.093.; Deibele A.J., Jennings L.K., Tcheng J.E. et al. Intracoronary Eptifibatide Bolus Administration During Percutaneous Coronary Revascularization for Acute Coronary Syndromes With Evaluation of Platelet Glycoprotein IIb/IIIa Receptor Occupancy and Platelet FunctionThe Intracoronary Eptifibatide (ICE) Trial. Circulation. 2010;121:784-91. doi:10.1161/CIRCULATIONAHA.109.882746.; Thygesen K., Alpert J.S., Jaffe A.S. et al. The Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation. 2012;126:2020-35. doi:10.1161/CIR.0b013e 31826e1058.; Wahr D., Wang Y., Schiller N. et al. Left Ventricular Volumes Determined by Two-Dimensional Echocardiography in a Normal Adult Population. J Am Coll Cardiol. 1983;1(3):863-8.; Lang R.M., Bierig M., Devereux R.B. Recommendations for Chamber Quantification: A Report from the American Society of echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group. J Am Soc Echocardiogr. 2005;18:1440-63. doi:10.1016/j.echo. 2005.10.005; Soon D., Hwa H., Kong K. et al. Clinical outcomes of intracoronary eptifibatide bolus only versus intracoronary bolus and intravenous infusion of eptifibatide in primary percutaneous coronary intervention. Acute Cardiac Care. 2012;14(1):42-4. doi:10.3109/17482941.2012.655288.; Iqbal Z., Cohen M., Pollack C. et al. ATOLL Investigators. Safety and Efficacy of Adjuvant Glycoprotein IIb/IIIa Inhibitors During Primary Percutaneous Coronary Intervention Performed From the Radial Approach for Acute ST Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2013;111(12):1727-33. doi:10.1016/j.amjcard.2013.02.020.; Fullard J.F. The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm Des. 2004;10(14):1567-76. doi:10.2174/1381612043384682.; Friedland S., Eisenberg M.J., Shimony A. Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2011;108:1244-5. doi:10.1016/j.amjcard.2011.06.039.; Gu Y.L., Fokkema M.L., Kampinga M.A. et al. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: The Comparison of Intracoronary Versus Intravenous Abciximab Administration During Emergency Reperfusion of ST-Segment Elevation Myocardial Infarction (CICERO) Trial. Circulation. 2010;122:2709. doi:10.1161/CIRCULATIONAHA.110.002741.; Deibele A.J., Jennings L.K., Tcheng J.E. et al. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: The intracoronary eptifibatide (ICE) trial. Circulation. 2010;121:784-91. doi:10.1161/CIRCULATIONAHA.109.882746.; Thiele H., Wöhrle J., Hambrecht R. et al. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: AIDA-4 randomised trial. Lancet. 2012;379(9819):923-31. doi:10.1016/S0140-6736(11) 61872-2.; Kubica J.,Koziński M., Navarese E.P., et al. Updated evidence on intracoronary abciximab in ST-elevation myocardial infarction: A systematic review and meta-analysis of randomized clinical trials. Cardiol J. 2012;19:230-42.; Eitel I., Wöhrle J., Suenkel H. et al. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA-STEMI trial. J Am Coll Cardiol. 2013;61:1447-54. doi:10.1016/j.jacc.2013.01.048.; Amir E., Mohammad F., Abbas A., Morteza E. Comparison between the Outcomes of Intracoronary and Intravenous Administration of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction. Journal of Atherosclerosis and Thrombosis. 2015;22:125. doi:10.5551/jat.30965.; Sanati H.R., Zahedmehr A., Firouzi A. et al. Intracoronary versus Intravenous eptifibatide during percutaneous coronary intervention for acute ST-segment elevation myocardial infarction; a randomized controlled trial. Cardiovasc Interv Ther. 2017;23:351-7. doi:10.1007/s12928-016-0418-9.; https://www.rpcardio.com/jour/article/view/1853

Availability: https://www.rpcardio.com/jour/article/view/1853
https://doi.org/10.20996/1819-6446-2019-15-1-17-28

View record from BASE

7

Academic Journal

INVASIVE TREATMENT STRATEGY FOR ACUTE MYOCARDIAL INFARCTION IN KEMEROVO REGION. PREREQUISITES, RESULTS AND PERSPECTIVES ; ИНВАЗИВНАЯ СТРАТЕГИЯ ЛЕЧЕНИЯ ОСТРОГО ИНФАРКТА МИОКАРДА В КЕМЕРОВСКОЙ ОБЛАСТИ. ПРЕДПОСЫЛКИ, ИТОГИ И ПЕРСПЕКТИВЫ

Authors: А. L. Murashkovskiy, А. Л. Мурашковский

Source: Complex Issues of Cardiovascular Diseases; № 1 (2013); 60-62 ; Комплексные проблемы сердечно-сосудистых заболеваний; № 1 (2013); 60-62 ; 2587-9537 ; 2306-1278 ; 10.17802/2306-1278-2013-1

Subject Terms: первичное чрескожное коронарное вмешательство (ЧКВ), «Stent for Life» initiative, delay of primary PCI, инициатива «Stent for Life»

File Description: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/9/12; ESC Guidelines for the management of acut myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology / H. G. Steg [et al.] // Eur. Heart J. 2012. Vol. 33(20). P. 2569–2619.; Implementation of primary angio plasty in Europe: stent for life initiative progress report / S. D. Kristensen [et al.] // EuroIntervention. 2012. Vol. 8. P. 35–42.; Karamfi loff R., Jorgova J. Decreasing STEMI mortality by implementing a PPCI network in Bulgaria // EuroIntervention. 2012. Vol. 8. P. 94–98.; Reperfusion Therapy for ST Elevation Myocardial Infarction in Europe: description of the current situation in 30 countries / P. Widimsky [et al.] // Eur. Heart J. 2010. Vol. 31. P. 943–957.; Stent for Life Initiative – the Greek experience / J. Kanakakis [et al.] // EuroIntervention. 2012. Vol. 8. P. 116–120.

Availability: https://www.nii-kpssz.com/jour/article/view/9
https://doi.org/10.17802/2306-1278-2013-1-60-62

View record from BASE

8

Academic Journal

EFFECTIVENESS OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION AND POLYVASCULAR ARTERY DISEASE ; ЭФФЕКТИВНОСТЬ ПЕРВИЧНОГО ЧРЕСКОЖНОГО КОРОНАРНОГО ВМЕШАТЕЛЬСТВА У БОЛЬ НЫХ С ИНФАРКТОМ МИОКАРДА С ПОДЪЕМОМ СЕГМЕНТА ST И СОПУТСТВУЮЩ ИМ МУЛЬТИФОКАЛЬНЫМ АТЕРОСКЛЕРОЗОМ

Authors: M. A. Sinkov, V. I. Ganyukov, М. А. Синьков, В. И. Ганюков

Source: Complex Issues of Cardiovascular Diseases; № 3 (2013); 57-61 ; Комплексные проблемы сердечно-сосудистых заболеваний; № 3 (2013); 57-61 ; 2587-9537 ; 2306-1278 ; 10.17802/2306-1278-2013-3

Subject Terms: первичное чрескожное коронарное вмешательство, ST elevation myocardial infarction, primary percutaneous coronary interventions, инфаркт миокарда с подъемом сегмента ST

File Description: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/30/34; Оганов Р. Г., Масленникова Г. Я. Сердечно-сосудистые заболевания в Российской Федерации во второй половине XX столетия: тенденции, возможные причины, перспективы // Кардиология. 2001. № 4. С. 8–11.; A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass / A. Naylon [et al.] // E. J. Vasc. Endovasc. Surgery. 2003. Vol. 25, № 5. P. 380–389.; Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain / I. Kallikararos [et al.] // Stroke. 1999. Vol. 30. P. 1002–1007.; Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial / G.W. Stone [et al.] // Circulation. 1999. Vol. 99. P. 1548–1554.; Coronary angiography in 506 patients with extracranial cerebrovascular disease / N. Hertzer [et al.] // Arch. Intern. Med. 1985. Vol. 145. P. 849–852.; Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group / C. L. Grines [et al.] // N. Engl. J. Med. 1999. Vol. 341. P. 1949–1956.; Despotovic N., Zdravkovic M. Multivascular disease in clinical practice // SrP. Arh. Celok. Lek. 2002. Vol. 130 (9–10). P. 316–319.; For the REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis / P. G. Steg [et al.] // JAMA. 2007. Vol. 297. P. 1197–1206.; Rothwell P. M. The interrelation between carotid, femoral and coronary artery disease // Eur. Heart J. 2001. Vol. 22, № 1. P. 11–14.; The Influence of Peripheral Arterial Disease on Outcomes: A Pooled Analysis of Mortality in Eight Large Randomized Percutaneous Coronary Intervention Trials / J. Saw [et al.] // J. Am. Coll. Cardiol. 2006. Vol. 48 (17). P. 1567–1572.

Availability: https://www.nii-kpssz.com/jour/article/view/30
https://doi.org/10.17802/2306-1278-2013-3-57-61

View record from BASE

9

Academic Journal

FACTORS OF MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH MULTIVESSEL CORONARY DISEASE AFTER ENDOVASCULAR REVASCULARIZATION ; ФАКТОРЫ ЛЕТАЛЬНОСТИ У БОЛЬНЫХ С ИНФАРКТОМ МИОКАРДА С ЭЛЕВАЦИЕЙ СЕГМЕНТА ST ПРИ МНОГОСОСУДИСТОМ ПОРАЖЕНИИ КОРОНАРНОГО РУСЛА ПОСЛЕ ЭНДОВАСКУЛЯРНОЙ РЕВАСКУЛЯРИЗАЦИИ

Authors: R. S. Tarasov, V. I. Ganukov, Р. С. Тарасов, В. И. Ганюков

Source: Complex Issues of Cardiovascular Diseases; № 1 (2015); 32-38 ; Комплексные проблемы сердечно-сосудистых заболеваний; № 1 (2015); 32-38 ; 2587-9537 ; 2306-1278 ; 10.17802/2306-1278-2015-1

Subject Terms: факторы летального исхода, multivessel coronary disease, primary PCI, factors of fatal outcome, многососудистое поражение коронарного русла, первичное чрескожное коронарное вмешательство

File Description: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/113/115; Чазов Е . И . Инфаркт миокарда – прошлое, настоящее и некоторые проблемы будущего. Сердце. 2002; 1:6–8. Chazov E. I. Myocardial infarction – past, present, and some of the problems of the future. Serdze. 2002; 1:6–8. [In Russ].; Ощепкова Е . В ., Ефремова Ю. Е ., Карпов Ю. А . Заболеваемость и смертность от инфаркта миокарда в Российской Федерации в 2000–2011 гг. Терапевтический архив. 2013; 4:4–10. Oshepkova E. V., Efremova Yu. E., Karpov Yu. A. Myocardial infarction morbidity and mortality in the Russian Federation in 2000–2011. Terapevticheskii arkhiv. 2013; 4: 4–10. [In Russ].; Ганюков В . И . Организация быстрого доступа больных инфарктом миокарда с подъемом сегмента ST в цен тры первичного ЧКВ. Комплексные проблемы сердечнососудистых заболеваний. 2013; 1:44–51. Ganyukov V. I. Short time delivery of STEMI patients to PCI centers. Complex Issues of cardiovascular diseases. 2013; 1: 44–51. [In Russ].; Dambrink J. H., Debrauwere J. P., van‘t Hof A. W., Ottervanger J. P., Gosselink A. T., Hoorntje J. C. et al. Nonculprit lesions detected during primary PCI: treat invasively or follow the guidelines? Eurointervention. 2010; 5:968–975.; Cardarelli F., Bellasi A., Ou F. S., Shaw L. J., Veledar E., Roe M. T. et al. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am. J. Cardiol. 2009; 103: 766–771.; Addala S., Grines C. L., Dixon S. R., Stone G. W., Boura J. A., Ochoa A. B. et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am. J. Cardiol. 2004; 93:629–632.; Halkin A., Singh M., Nikolsky E., Grines C. L., Tcheng J. E., Garcia E. et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J. Am. Coll. Cardiol. 2005; 45:1397–1405.; Eagle K. A., Lim M. J., Dabbous O. H. GRACE Investigators et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004; 291:2727–2733.; De Luca G., Suryapranata H., van‘t Hof A. W., de Boer M. J., Hoorntje J. C., Dambrink J. H. et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation. 2004; 109:2737–2743.; Windecker S., Kolh P., Alfonso F., Collet J. P., Cremer J., Falk V. et al. 2014 ESC/EACTS Guidelines onmyocardial revascularization. Eur. Heart J. 2014; 278:25-27. doi:10.1093/ eurheartj/ehu.; Wald D. S., Morris J. K., Wald N. J., Chase A. J., Edwards R. J., Hughes L. O. et al. Randomized trial of preventive angioplasty in myocardial infarction. N. Engl. J. Med. 2013; 369(12):1115–1123.; Erne P. Radovanovic D., Urban Ph., Stauffer J. Ch., Bertel O., Gutzwiller F. et al. Early drug therapy and in-hospital mortality following acute myocardial infarction. Heart Drug. 2003: 3:34–140.; Hochman J. S., Tamis J. E., Thompson T. D., Weaver W. D., White H. D., Van de Werf F. et al. Sex, Clinical Presentation, and Outcome in Patients with Acute Coronary Syndromes. N. Engl. J. Med. 1999; 341:226–232.; Haq I., Sharif M. A. In-hospital Mortality after Acute Myocardial infarction. Pakistan’s J. Med. Sci. 1993; 9: 249–251.; Tarasov R. S., Ganyukov V. I., Protopopov A. V., Barbarash O. L., Barbarash L. S. Six month results of randomized clinical trial: Multivessel stenting versus staged revascularization for ST-elevation myocardial infarction patients with second generation drug eluting stents. Clinical Medicine Research. 2014; 3(5):125–129. doi:10.11648/j.cmr. 20140305.12.

Availability: https://www.nii-kpssz.com/jour/article/view/113
https://doi.org/10.17802/2306-1278-2015-1-32-38

View record from BASE

10

Academic Journal